Center Publications

Caslin, Heather L, et al. “Adipose Tissue Macrophages: Unique Polarization and Bioenergetics in Obesity”. 2020. Immunological Reviews, vol. 295, no. 1, 2020, pp. 101–113.

Wei, Xiaochao, et al. “Endothelial Palmitoylation Cycling Coordinates Vessel Remodeling in Peripheral Artery Disease”. 2020. Circulation Research, vol. 127, no. 2, 2020, pp. 249–265.

Jia, Tongqiu, et al. “Thousands of Missing Variants in the UK Biobank Are Recoverable by Genome Realignment”. 2020. Annals of Human Genetics, vol. 84, no. 3, 2020, pp. 214–220.

Morozov, Darya, et al. “Toward Noninvasive Quantification of Adipose Tissue Oxygenation With MRI”. 2020. International Journal of Obesity (2005), vol. 44, no. 8, 2020, pp. 1776–1783.

Verma, Subodh, et al. “Empagliflozin Reduces the Risk of Mortality and Hospitalization for Heart Failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes Categories: Post Hoc Analysis of the EMPA-REG OUTCOME Trial”. 2020. Diabetes, Obesity & Metabolism, vol. 22, no. 7, 2020, pp. 1141–1150.

Sousa, Giovane R, et al. “Cardiac Autoimmunity Is Associated With Subclinical Myocardial Dysfunction in Patients With Type 1 Diabetes Mellitus”. 2020. Circulation, vol. 141, no. 13, 2020, pp. 1107–1109.

Atchison, Douglas K, et al. “Hypertension Induces Glomerulosclerosis in Phospholipase C-ε1 Deficiency”. 2020. American Journal of Physiology. Renal Physiology, vol. 318, no. 5, 2020, pp. F1177-F1187.

Docherty, Kieran F, et al. “Effects of Dapagliflozin in DAPA-HF According to Background Heart Failure Therapy”. 2020. European Heart Journal, vol. 41, no. 25, 2020, pp. 2379–2392.

Chopra, Deeksha G, et al. “Deletion of Gpr27 in Vivo Reduces Insulin MRNA But Does Not Result in Diabetes”. 2020. Scientific Reports, vol. 10, no. 1, 2020, p. 5629.

Darcy, Justin, et al. “Analyzing Mitochondrial Function in Brown Adipocytes With a Bioenergetic Analyzer”. 2020. Methods in Molecular Biology (Clifton, N.J.), vol. 2138, 2020, pp. 289–296.

Petrie, Mark C, et al. “Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes”. 2020. JAMA, vol. 323, no. 14, 2020, pp. 1353–1368.

Sutton, Amy K, et al. “Paraventricular, Subparaventricular and Periventricular Hypothalamic IRS4-Expressing Neurons Are Required for Normal Energy Balance”. 2020. Scientific Reports, vol. 10, no. 1, 2020, p. 5546.